Health Industry

Latest KFF Health News Stories

Pelosi Aims For Feds To Negotiate Drug Prices, Even For Private Insurers

KFF Health News Original

A draft plan spearheaded by House Speaker Nancy Pelosi would allow the federal government for the first time to negotiate prices for 250 drugs for Medicare and apply those prices to all payers, including employers and insurers.

Delaney’s Debate Claim That ‘Medicare For All’ Will Shutter Hospitals Goes Overboard

KFF Health News Original

At the first Democratic presidential primary debate, former U.S. lawmaker John Delaney outlined his opposition to “Medicare for All” by claiming it would prove fatal for hospitals. It’s really not that simple.

KHN’s ‘What The Health?’: Dems Debate Health Care

KFF Health News Original

Democratic presidential candidates disagreed on how to fix health care in their first debate Wednesday, although they all called for boosting insurance coverage and lowering prices. Meanwhile, the Trump administration is keeping health care in the news, too, with a new plan to make medical prices more available to the public. Stephanie Armour of The Wall Street Journal, Rebecca Adams of CQ Roll Call and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this, plus the latest in news about bipartisan progress on catch-all legislation to address “surprise” medical bills. Plus, Rovner interviews NPR’s Jon Hamilton about the latest KHN-NPR “Bill of the Month” installment.

‘Medicare For All’ Emerges As Early Divide In First Democratic Debate

KFF Health News Original

On the first of the Democrat’s two-night debate, only New York City Mayor Bill de Blasio and Massachusetts Sen. Elizabeth Warren offered full support for a single-payer system that would banish private health insurance.

Opioid Operators: How Surgeons Ply Patients With Painkillers

KFF Health News Original

Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.

Sen. Alexander Details His Plan To Fix Surprise Medical Bills

KFF Health News Original

A legislative package from Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) would handle surprise medical bills by having insurers pay them the “median in-network rate,” meaning the rate would be similar to what the plan charges other doctors in the area for the same procedure.

Senators Agree Surprise Medical Bills Must Go. But How?

KFF Health News Original

The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.

Miracle Machine Makes Heroic Rescues — And Leaves Patients In Limbo

KFF Health News Original

The use of ECMO, the most aggressive form of life support in modern medicine, has skyrocketed — but along with miraculous rescues, it can leave patients in limbo, kept alive with machines but with no prospect of survival outside the ICU.

In Combating Surprise Bills, Lawmakers Miss Sky-High Air Ambulance Costs

KFF Health News Original

The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

KFF Health News Original

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?

KFF Health News Original

The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.